Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Thom

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
The Lancet. Global Health|September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trialThomas Lung, Stephen Jan, H Asita de Silva, et al.
International Journal of Cardiology|January 7, 2016
Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countriesRuth Webster, Anushka Patel, Vanessa Selak, et al.
International Journal of Cardiology|October 23, 2013
Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE CollaborationRuth Webster, Anushka Patel, Laurent Billot, et al.
Lancet (London, England)|February 14, 2017
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic reviewClara K Chow, Jay Thakkar, Alex Bennett, et al.
Heart (British Cardiac Society)|June 30, 2018
Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trialsVanessa Selak, Ruth Webster, Sandrine Stepien, et al.
JAMA|August 19, 2018
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical TrialRuth Webster, Abdul Salam, H Asita de Silva, et al.
Circulation|November 12, 2019
Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITARasha K Al-Lamee, Matthew J Shun-Shin, James P Howard, et al.
Nature Genetics|January 31, 2017
Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular riskHelen R Warren, Evangelos Evangelou, Claudia P Cabrera, et al.
Nature Genetics|September 28, 2017
Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular riskHelen R Warren, Evangelos Evangelou, Claudia P Cabrera, et al.
American Journal of Human Genetics|November 22, 2011
Blood pressure loci identified with a gene-centric arrayToby Johnson, Tom R Gaunt, Stephen J Newhouse, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Lancet. Global Health|September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trialThomas Lung, Stephen Jan, H Asita de Silva, et al.
International Journal of Cardiology|January 7, 2016
Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countriesRuth Webster, Anushka Patel, Vanessa Selak, et al.
International Journal of Cardiology|October 23, 2013
Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE CollaborationRuth Webster, Anushka Patel, Laurent Billot, et al.
Lancet (London, England)|February 14, 2017
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic reviewClara K Chow, Jay Thakkar, Alex Bennett, et al.
Heart (British Cardiac Society)|June 30, 2018
Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trialsVanessa Selak, Ruth Webster, Sandrine Stepien, et al.
JAMA|August 19, 2018
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical TrialRuth Webster, Abdul Salam, H Asita de Silva, et al.
Circulation|November 12, 2019
Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITARasha K Al-Lamee, Matthew J Shun-Shin, James P Howard, et al.
Nature Genetics|January 31, 2017
Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular riskHelen R Warren, Evangelos Evangelou, Claudia P Cabrera, et al.
Nature Genetics|September 28, 2017
Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular riskHelen R Warren, Evangelos Evangelou, Claudia P Cabrera, et al.
American Journal of Human Genetics|November 22, 2011
Blood pressure loci identified with a gene-centric arrayToby Johnson, Tom R Gaunt, Stephen J Newhouse, et al.
Pageof 6